Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
19 June 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
talactoferrin Articles
Agennix views options, including partners or liquidation
11 April 2013
Agennix plunges as talactoferrin fails in NSCLC Ph III trial
9 August 2012
Lonza and Agennix link up for talactoferrin production
12 April 2012
Positive outlook seen for Agennix’ talactoferrin in cancer and sepsis treatment, but firm needs to raise funds, say analysts
1 April 2010
Showing 1-4 of 4 articles
1
Hot Topics
Most Read
InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
Additional indications in Japan for Roche's Avastin and Astellas' Prograf
US Supreme Court says patent settlement can "sometimes" be illegal
InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
Additional indications in Japan for Roche's Avastin and Astellas' Prograf
US Supreme Court says patent settlement can "sometimes" be illegal